Drug
Regn1033
Regn1033: highest development phase Phase 1, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| REGN1033(SAR391786) NCT01507402 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Regn1033 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.